Crispr Therapeutics AG vs eBay Inc — how do they compare? Crispr Therapeutics AG trades at $53.88 (market cap $5.17B), while eBay Inc trades at $106.06 (market cap $47.93B). The key difference: eBay Inc is far larger — about 9.3× Crispr Therapeutics AG's market cap, and eBay Inc pays a 1.15% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.
| CRSP | EBAY | |
|---|---|---|
Market Cap | $5.17B | $47.93B |
Sector | Health | Consumer Cyclical |
52-Week High | $76.78 | $118.96 |
52-Week Low | $44.34 | $79.41 |
Enterprise Value | $3.59B | $51.75B |
Volume | — | 5,186,418 |
Dividend Yield | — | 1.15% |
Trailing returns across standard periods
Latest headlines on both assets
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →